Thakker Ravi A, Salazar Leonardo, Jazar Deaa Abu, Bhakta Pooja, Baker Bryan, Patel Chandani, Elbadawi Ayman, Agarwal Mayank, Albaeni Aiham, Saleh Mohammed, Esclovan Jonathan, El Haddad Danielle, Alwash Hashim, Kalra Ankur, Goel Sachin S, Widmer Robert Jay, Chatila Khaled, Khalife Wissam, Motiwala Afaq, McCracken Jennifer, Jneid Hani, Gilani Syed
Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Division of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Cardiol Ther. 2022 Jun;11(2):175-183. doi: 10.1007/s40119-022-00255-9. Epub 2022 Mar 28.
Aspirin is one of the most widely used medications across the global healthcare system and is the foundation in treating ischemic heart disease, as well as secondary prevention for ischemic and valvular heart disease. Challenges arise in treating patients with cardiovascular disease who have concomitant aspirin intolerance. Through an extensive review of the literature, we provide a comprehensive background on the pharmacology of aspirin, the mechanisms behind aspirin intolerance, the importance of aspirin in cardiovascular disease, and the management of aspirin intolerance in both acute coronary syndrome and stable coronary artery disease. Our review includes a multidisciplinary approach from the internist, allergist/immunologist, and cardiologist when evaluating this important patient population.
阿司匹林是全球医疗体系中使用最广泛的药物之一,是治疗缺血性心脏病的基础药物,也是缺血性和瓣膜性心脏病二级预防的基础药物。在治疗合并阿司匹林不耐受的心血管疾病患者时会出现挑战。通过广泛查阅文献,我们提供了关于阿司匹林药理学、阿司匹林不耐受背后的机制、阿司匹林在心血管疾病中的重要性以及急性冠状动脉综合征和稳定型冠状动脉疾病中阿司匹林不耐受管理的全面背景知识。我们的综述在评估这一重要患者群体时采用了内科医生、过敏症专科医生/免疫学家和心脏病专家的多学科方法。